Updated: 29 Jun 2009
Short term treatment of severe, intractable insomnia, in patients habituated to barbiturates.
Orange/blue capsules coded F65.
Secobarbital [quinalbarbitone] sodium, amobarbital sodium [amylobarbitone sodium]
Capsules, secobarbital sodium 50mg, amobarbital sodium (amylobarbitone sodium) 50mg.
100 - 200 mg at bedtime.
Liver disorders, renal impairment, severe pulmonary insufficiency. Tolerance and dependence may develop.
Hangover with drowsiness, dizziness, ataxia, respiratory depression, hypersensitivity reactions, headache, paradoxical excitement and confusion.
Uncontrolled pain, young adults, the elderly and debilitated, pregnancy, lactation, patients with a history of alcohol or drug abuse, acute intermittent porphyria.
This new CME activity covers the best-practice management and treatment of nocturnal enuresis through three case study-led modules including a more severe and complex patient scenario.